Pharma Industry News
Printable Version   Email to a friend

Thar Instruments Completes the Acquisition of Berger SFC Business from METTLER TOLEDO

PITTSBURGH--(BUSINESS WIRE)--Jul 2, 2007 - Thar Instruments, a global leader in the design, development and manufacture of Supercritical Fluid Chromatography (SFC) systems announced the acquisition of Berger SFC(R) division of METTLER TOLEDO. Berger SFC(R) is a pioneer in the development of SFC and a world leader in SFC Analysis and Purification. The combination of the top two supercritical fluid technology companies will enable the advancement of new technologies and applications, and expand capabilities in the support and service of its customers in pharmaceutical drug discovery and development globally.

"We are pleased that we have completed this acquisition," says Thar CEO, Dr. Lalit Chordia. "Berger SFC brings a global reputation and deep experience in the development of Supercritical Fluid Chromatography. We are excited about future advancement to broaden the scope of SFC technology as a result of this acquisition.

"We continue to believe that the SFC market represents an exciting opportunity. The combination of Berger SFC and Thar Instruments will result in a fully integrated SFC instrumentation company that will have the necessary critical mass to further penetrate the rapidly developing analysis and purification market, while providing competent support and service to customers around the world."

SFC is at least three to five times faster than HPLC. The high resolution of SFC makes it ideal for the separation and purification of difficult chemical samples, such as chiral enantiomers and natural products. SFC is generally known as normal phase chromatography, thereby offering a complimentary selectivity to HPLC but much greener because it reduces solvent usage by an average of 80%.

Sometimes referred to as "green chromatography," SFC is now used in every major pharmaceutical drug discovery lab to support the analysis and purification of potential new drug compounds. The use of SFC is expanding quickly, once viewed as a specialist technique only used in the US, UK and France, now chromatographers all over the world are using this fast, green technique. After the merger of the two technology and markets leaders, most of the world's SFC design and fabrication expertise will be under one roof including important patents on the instrumentation. For more information, visit www.thartech.com.

About Thar Instruments

Thar Instruments is a global leader in the design, development and manufacture of analytical and preparative SFC and SFE (extraction) systems. Thar's expertise has been applied to a wide variety of research in industries including petrochemicals, food, flavors, pharmaceuticals, nutraceuticals and fine chemicals. In recent years, Thar has developed applications for separating compounds that cannot be resolved using traditional techniques such as HPLC and GC. Apart from pharmaceutical compounds, other products analyzed by SFC include pesticides, food contaminants, engine fuels, polymers and peptides.

About METTLER TOLEDO

METTLER TOLEDO develops and manufactures precision instruments for weighing, analytical chemistry and materials characterization, chemical discovery and development, process analysis, metal detection and other end-of-line inspection requirements. With more than 10,000 employees, METTLER TOLEDO sells and supports its products and services world-wide to customers in the life science, food processing and packaging, retailing, specialty chemicals and cosmetics, transportation, logistics, metals and electronics industries. For more information visit www.mt.com.

Contact

Thar Instruments
Magali Curiel, +1 412-967-5665 x219

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
September 4, 2008
Audience: Rheumatological, gastroenterological and infectious disease healthcare professionals[Posted 09/04/2008] FDA notified...
September 1, 2008
Audience: Emergency healthcare professionals, military emergency/disaster/field hospital/aviation personnel [Posted 08/28/2008]...
August 25, 2008
Audience: Neurologists, other healthcare professionals, patients[Posted 08/25/2008] FDA informed healthcare professionals of two...
August 21, 2008
Audience: Endocrinologists, cardiologists, other healthcare professionals, patients[Posted 08/21/2008] FDA informed healthcare...
More...
Latest Drug Information Updates

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

More...